Company intelligence
Bayer
About Bayer
Bayer is a global enterprise with core competencies in the life science fields of healthcare and nutrition. We design our products and services to serve the most essential human needs of health and nutrition. At the same time, we strive to address some of the world’s biggest challenges presented by a growing and aging global population. At Bayer, we’re committed to driving sustainable development and generate a positive impact with our businesses. Through the power of science, we’re pioneering new possibilities that advance life for all of us. That means reimagining how we care for ourselves and one another by empowering everyday health, improving approaches to patient care, and finding better ways to nourish our communities around the world. Data Privacy Statement & Imprint: https://www.bayer.com/en/glob-li-bayer-en-dps-imprint
Verified activity
Signals from Bayer
81 published signals
Presence & Recognition
Bayer used AI-powered coding at the ESC Congress to turn real-world clinical challenges into rapid digital prototypes, apps, and predictive tools.
Reported by Bayer
Presence & Recognition
Bayer showcased its crop science innovations and collaborated with Cocamar Cooperativa Agrindustrial.
Reported by Ana Oliveira
Presence & Recognition
Bayer participated in the Vulkan Haut Spektrum Dermatologie Kongress as a guest speaker.
Reported by Dr. rer. nat. Tanju Yesilkaya
Presence & Recognition
Bayer hosted a round table focused on Cell Therapy Analytics at the HubXchange conference in San Francisco.
Reported by Jigesha Dholakia
Presence & Recognition
Bayer shared the experiences of over 3,000 colleagues across 66 countries to better understand the realities of menopause at work.
Reported by Bayer
Presence & Recognition
Bayer employee Samia Dorpinghaus will open the CHCI Hispanic Heritage Month Leadership Conference conversation titled Feeding Growth: Innovation and Sustainability in Global Agriculture.
Reported by Samia Dorpinghaus
Research & Knowledge
Bayer is experimenting with Blender to create Fall out 4 style art based off 2D images with a high poly count.
Reported by Chris Dillman
Presence & Recognition
Bayer held a packed few days in Huxley, full of learning and reconnecting with colleagues from across the business.
Reported by Elzandi Oosthuizen
Presence & Recognition
Bayer participated in DAY 1 of ORCHEM2026, featuring talks and poster presentations by Daniele Leonori, Max Hansmann, and Helma Wennemers.
Reported by Carl Nising
Research & Knowledge
Bayer shared the first video in its three-part series with Seed World Europe on the people, science, and persistence behind modern seed innovation.
Reported by Frank Terhorst
Presence & Recognition
Bayer represented its science community at the Science Delivers event
Reported by Beth Roden
Presence & Recognition
Bayer | Pharmaceuticals organized a panel discussion on World Menopause and Work Day featuring Dr. Kristie Baisden, Katie Bang, Valerie Baroin, and Rubén Alejandro Ramírez at Menopause@Bayer
Reported by Heike Prinz
Presence & Recognition
Bayer visited Petrolina, Brazil to reflect on how different parts of the R&D network contribute to the same goal.
Reported by Johannes Daniël (JD) Rossouw
Research & Knowledge
Bayer published ASTRA 2D to 3D workflow test results.
Reported by Chris Dillman
Products & Services
Bayer launched Astra 3D art generation test, which takes a 2D image and turns it into a 3D textured asset with lighting and game-ready features.
Reported by Chris Dillman
Products & Services
Bayer ported Metroid for NES to a 8mhz Mac Plus including sound and music.
Reported by Chris Dillman
Research & Knowledge
Bayer is running a 3D Astra art generation test in GODOT.
Reported by Chris Dillman
Partnerships
Bayer is expanding its reach to smallholders across African countries through partnerships with The World Bank Group, International Fund for Agricultural Development (IFAD), and the African Development Bank Group.
Reported by Cristiane Lourenço
Presence & Recognition
Bayer is hosting the new edition of Science Unplugged Talks titled AI or Me for a live conversation about the future of data-driven innovation, human choices, and science that matters.
Reported by Bayer
Presence & Recognition
Bayer hosted the Bayer | Crop Science Huxley Innovation Showcase at the Huxley, IA site this past week to bring the innovation story to external audiences.
Reported by Kelley Wright
Capital & Finance
Bayer made 200+ grants totaling $4.7 million to central Texas nonprofit organizations through the Women’s Fund of the Austin Community Foundation.
Reported by Emily Durden, PhD
Presence & Recognition
Bayer spent many days on the farm in Huxley, IA during the very early days of Mike Graham's career.
Reported by Mike Graham
Research & Knowledge
Bayer showcased DKC68-35, a hybrid bred from Mexico, Thailand, Argentina, and the U.S., reaching 400+ bu/acre in the 2025 NCGA Yield Contest.
Reported by Elzandi Oosthuizen
Presence & Recognition
Bayer Pharmaceuticals & President Bayer U.S. joined leaders from healthcare, government, academia, and industry in Barcelona to discuss innovation and patient outcomes.
Reported by Sebastian Guth